Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07090109

PITCH - Impacting Hereditary Cancer Testing

The goal of this clinical trial is to assess patients' knowledge and attitudes about genetic testing before and after viewing an educational video. The main questions it aims to answer are:

* Did the video change participants' knowledge and attitudes about genetic testing? * Did participants make an informed choice about pursuing genetic testing?

Participants will:

* Complete a baseline survey * View educational video * Complete follow-up survey

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Ovarian Cancer Adnexal Diseases Endocrine Gland Neoplasms Endocrine System Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genetic Counseling Genetic Testing Genital Diseases Genital Diseases, Female Genital Neoplasms, Female Gonadal Disorders Neoplasms Neoplasms by Site Ovarian Diseases Ovarian Neoplasms Urogenital Diseases Urogenital Neoplasms

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

University of Kentucky

Lexington, Kentucky, 40506, United States

Location contact

Justine Pickarski

CONTACT

[email protected]

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • diagnosed with a cancer that can be associated with hereditary forms of cancer

Exclusion criteria

  • previously undergone multi-gene panel testing for hereditary cancers

Treatment and study plan

Genetic testing education video

Behavioral

patient education video about genetic testing for hereditary cancers

Primary outcomes

  1. Change in Multi-Dimensional Measure of Informed Choice (MMIC) - Cancer Knowledge Scale

    Time frame: Baseline and post intervention (approximately 30 minutes)

    The MMIC is a compound assessment tool with three elements which are used together to differentiate an informed choice from a less informed choice. An informed choice is demonstrated by: Achieving =75% (6 of 8 questions) correct responses on the knowledge scale AND Making a decision that is in keeping with one's values related to the outcome (positive vs. negative) A less informed choice is demonstrated by: Achieving <75% correct responses on the knowledge scale OR Achieving =75% correct responses on the knowledge scale but making a decision that is inconsistent with one's values (e.g., a patient values the information that may be obtained but chose not to undergo testing OR a patient does not value the information and chose to undergo testing)

Secondary outcomes

  1. Number of participants completing genetic testing

    Time frame: 90 days

    Number of participants that complete testing after the intervention

Study contacts

Contact information is provided by the study sponsor or research team.

Justine Pickarski

CONTACT

[email protected]

859-323-9697

Sponsors and collaborators

Lead sponsor

Rachel Miller

Other

Registry information

Official study title

Partnering to Impact Testing in the Commonwealth for Hereditary Cancers (PITCH)

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jul 29, 2025
Registry last updated
Jun 25, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.